Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Gupta is currently an Oncology Fellow at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

For information on Dr. Gupta see the following links - 

Hopkins Medicine Kimmel Cancer Center

ASCO

Supportive Care Video Series 2019 - Aromatase Inhibitor Induced Arthralgia (AI Induced Arthralgia)
Author
Arjun Gupta, MD, Advisory Board Member, GRACE Faculty
Image

GRACE is very excited to bring you more of our program on supportive care in cancer treatment.

Arjun Gupta, MD, one of the GRACE Fellows Ambassador Program Winners for 2019 is the host of this video series, Supportive Care in Cancer Treatment. In this video, Dr. Gupta's guest is Dr. Dawn Hershman, with Columbia University in New York. Their topic of discussion is Aromatase Inhibitor Induced Arthralgia (AI Induced Arthralgia).

Aromatase inhibitors (ais) are commonly used as adjuvant treatment in postmenopausal women with hormone receptor–positive early breast cancer.  Arthralgia is often defined as an aching or pain in the joints without swelling, and can include stiffness, joint pain, redness and the reduced ability to move your joints.  This is not to be confused with arthritis -- which is more likely pain with swelling of the joints.  


 

For comments or questions, join the conversation, visit https://cancergrace.org/forums/general-breast-cancer.

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora